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Background: Sex-speciﬁc differences in fetal lung maturation have been well described;
however, little is known about the sex-speciﬁc differences in microRNA (miRNA)
expression during human fetal lung development. Interestingly, many adult chronic lung
diseases also demonstrate sex-speciﬁc differences in prevalence. The developmental
origins of health and disease hypothesis suggests that these sex-speciﬁc differences in
fetal lung development may inﬂuence disease susceptibility later in life. In this study, we
performed miRNA sequencing on human fetal lung tissue samples to investigate
differential expression of miRNAs between males and females in the pseudoglandular
stage of lung development. We hypothesized that differences in miRNA expression are
present between sexes in early human lung development and may contribute to the sexspeciﬁc differences seen in pulmonary diseases later in life.
Methods: RNA was isolated from human fetal lung tissue samples for miRNA sequencing.
The count of each miRNA was modeled by sex using negative binomial regression models
in DESeq2, adjusting for post-conception age, age2, smoke exposure, batch, and RUV
factors. We tested for differential expression of miRNAs by sex, and for the presence of
sex-by-age interactions to determine if miRNA expression levels by age were distinct
between males and females.
Results: miRNA expression proﬁles were generated on 298 samples (166 males and 132
females). Of the 809 miRNAs expressed in human fetal lung tissue during the
pseudoglandular stage of lung development, we identiﬁed 93 autosomal miRNAs that
were signiﬁcantly differentially expressed by sex and 129 miRNAs with a sex-speciﬁc
pattern of miRNA expression across the course of the pseudoglandular period.
Conclusion: Our study demonstrates differential expression of numerous autosomal
miRNAs between the male and female developing human lung. Additionally, the
expression of some miRNAs are modiﬁed by age across the pseudoglandular stage in
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a sex-speciﬁc way. Some of these differences in miRNA expression may impact
susceptibility to pulmonary disease later in life. Our results suggest that sex-speciﬁc
miRNA expression during human lung development may be a potential mechanism to
explain sex-speciﬁc differences in lung development and may impact subsequent disease
susceptibility.
Keywords: microRNA, lung development, pulmonary disease, sex-speciﬁc, gene expression, human

INTRODUCTION

Of particular interest are microRNAs (miRNAs), small
RNAs (~21–24 nucleotides) that are important regulators of
gene expression. miRNAs target protein-coding genes by
cleavage of target messenger RNA (mRNA), inhibition of
translation, and/or mRNA deadenylation (Bhaskaran et al.,
2009). A single miRNA can have many gene targets, with 30%
of the human genome thought to be miRNA targets (Lewis
et al., 2005). As such, miRNAs are essential regulators of many
critical biological processes. Animal models have previously
demonstrated the importance of miRNAs in lung
development, including airway growth and branching
morphogenesis. Proteins that are essential for miRNA
processing appear to have a prominent role in murine lung
development. For example, a seminal study showed that the
inactivation of Dicer, a protein required to generate mature
miRNAs, leads to signiﬁcant branching defects in mouse
embryonic lung tissue resulting in large epithelial pouches
(Harris et al., 2006). In addition, Ago1 and Ago2, members of
the Argonaute family which regulate small RNAs, were shown
to be enriched in the distal epithelium and mesenchyme of the
early developing lung, suggesting miRNA mediated gene
regulation occurs in a localized manner (Lü et al., 2005).
Speciﬁc miRNAs have also been shown to have a signiﬁcant
impact on the developing lung, including the overexpression of
miR-127 in early fetal rat lung development, which causes
defective branching and terminal bud formation (Bhaskaran
et al., 2009).
Animal models have also established that there are sexspeciﬁc differences in miRNA expression within the
developing lung (Mujahid et al., 2013) and that these sexspeciﬁc differences may impact subsequent disease risk. Given
this existing body of evidence, it is plausible that there are sex
differences in miRNA levels during early human lung
development, and that these sex-speciﬁc differences in
miRNA expression may impact subsequent disease risk.
However, to-date sex-speciﬁc differences in miRNA
expression have not been explored in human biospecimens,
particularly using high-throughput proﬁling methods. To
address this existing knowledge gap, we generated the ﬁrst
miRNA sequencing proﬁles of early human fetal lung tissue
samples to investigate differential miRNA expression between
developing male and female lungs during the pseudoglandular
stage of lung development. We hypothesize that differences in
miRNA expression are present in early human fetal lung
development between sexes, and this may be a mechanism
to explain sex-speciﬁc differences in susceptibility to
pulmonary diseases later in life.

Sex-speciﬁc differences in human lung maturation begin in
utero. Using histologic staging, the fetal lungs of human
females are more mature than males from 20 to 32 weeks of
gestation (Naeye et al., 1974). Measurements of the lecithinsphingomyelin ratio in fetuses between 28 and 40 weeks of
gestation also suggest that human female lungs are about
1.2–2.5 weeks more mature than male lungs (Torday et al.,
1981). However, the time point at which sexual differences
emerge in human lung development, the biological pathways
differing by sex, and the regulatory mechanisms underlying
these differences are not well understood. Using
transcriptomic proﬁling in human fetal lung tissue, we have
previously shown that sexual dimorphism in human lung
development occurs as early as the pseudglandular stage
(Kho et al., 2016a). In part, these differences are
hypothesized to be driven by sex hormones and sex-speciﬁc
differences in endogenous corticosteroid handling (Boucher
et al., 2014). For example, estrogens are known to alter
surfactant production (Seaborn et al., 2010). In addition,
glucocorticoids, which are known to be essential to lung
development, are inﬂuenced by endogenous androgens
during development in a sex-speciﬁc manner (Provost et al.,
2013). While these mechanisms are known to impact the
structural development of the lung in the later stages of
gestation, the impact of sex-speciﬁc differences in early lung
development have not been fully elucidated. Thus, better
characterization of sex-speciﬁc differences in early lung
development, a critical time period of airway growth and
branching morphogenesis, may offer insight into the
biological mechanisms that underlie sex-based differences in
respiratory disease.
Epigenetic regulation of human development is well
recognized and may provide insights into additional
mechanisms that explain sex-speciﬁc differences in lung
maturation. Furthermore, an understanding of the sexspeciﬁc epigenetic changes that regulate human lung
development may also help to understand the
developmental origins of diseases that exhibit sex-speciﬁc
differences in prevalence. For example, the ability to
characterize sex-speciﬁc differences in epigenetic processes
may offer insight into the biological mechanisms that
enhance susceptibility to childhood respiratory diseases
among males, including respiratory distress syndrome,
bronchopulmonary dysplasia, and childhood asthma (Naeye
et al., 1971).
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METHODS

TABLE 1 | Characteristics of human fetal lung samples analyzed.

Sample Acquisition and Phenotypic
Characteristics

N
Age (dpc)
IUS (exposed)

Human fetal lung tissue samples were collected as part of a
prenatal tissue retrieval program sponsored by the National
Institute of National Child Health and Development, the
University of Maryland Brain and Tissue Bank for
Developmental Disorders (Baltimore, MD), and the Center for
Birth Defects Research (University of Washington; Seattle, WA).
The study was designated an institutional review board (IRB)
exempt protocol by the University of Missouri-Kansas City
Pediatric IRB, Partners Human Research Committee IRB, and
the Colorado Multiple Institutional Review Board (COMIRB).
Due to sample de-identiﬁcation, limited maternal and fetal
phenotypic characteristics were available for each sample
including gestational age and sex. Sample sex was previously
conﬁrmed based on paired gene expression data (Kho et al.,
2016a) by classifying samples as female or male based on their
expression of X- and Y-chromosome genes. The age of samples
was determined using estimated days post-conception.
Intrauterine cigarette smoke exposure (based on placental
cotinine concentration) (Vyhlidal et al., 2013) is a well-known
confounder of fetal lung development and was directly measured
in the samples using the Cotinine Direct ELISA kit (Calbiotech,
Spring Valley, CA). Unmeasured confounders were accounted for
using the RUV method described below in miRNA proﬁling.

Male

All

132
87.0 (76.0, 96.5)
62 (47.0%)

166
89.0 (76.0, 96.0)
77 (46.4%)

298
87.0 (76.0, 96.0)
139 (46.6%)

2014), we modeled the count of each miRNA (outcome) by sample
sex (explanatory variable of interest; indicator variable for male or
female), adjusting for age and age squared (age2) (Torday et al., 1981)
(age is measured in days post-conception; age2 is a quadratic term to
capture potential non-linear effects), smoke exposure (≥or <7.5 ng
cotinine/g placenta), technical batch (indicator variable for batch 1,
2, 3, or 4), and four inferred covariates to capture additional
unmeasured confounders (k = 4 RUVr components). A
statistically signiﬁcant difference in mean miRNA levels by sex
was deﬁned by a likelihood ratio test at a multiple testing
corrected q-value (Storey, 2002) < 0.05.
Second, we screened for autosomal miRNAs with sex-speciﬁc
“age-trajectories” using a likelihood ratio test to evaluate whether
adding an age-by-sex interaction signiﬁcantly improved model
ﬁt. A signiﬁcant interaction (q-value < 0.05) implies that the
pattern of miRNA expression levels by age were distinct between
male and female participants. For example, a miRNA may
increase in male samples, yet decrease or remain the same in
female samples.
Functional Interpretation of Sex-Differing miRNAs. To interpret
the functional impact of miRNAs differentially expressed by sex and
with sex-speciﬁc age trajectories, we used miRNAtap (Pajak and
Simpson, 2021) to identify predicted gene expression targets
regulated by each miRNA. In addition, we sorted the list of
miRNAs tested by descending p-value and used pre-ranked gene
set enrichment analyses in miEAA to conduct pathway analyses
(Subramanian et al., 2005; Kern et al., 2020). Statistically signiﬁcant
enrichment in a pathway (q-value < 0.05) indicates that miRNAs
associated with the pathway appear at the top of the list (lower
p-values) more frequently than would be expected by random chance.
Annotations of miRNAs to pathways were based on the miRWalk 2.0
database, as curated by the miEAA developers (Dweep et al., 2011).

miRNA Proﬁling
We extracted total RNA from 30 mg of homogenized prenatal
lung tissue with the miRNeasy Mini Kit per manufacturer
instructions (Qiagen; Valencia, CA, United States). Samples
were block-randomized by age, sex, and smoke exposure status
to four batches of miRNA library preparation (Small RNA
Sequencing Kit v3 for Illumina Platforms; Bio Scientiﬁc) and
sequencing (HiSeq2500; Illumina; San Diego, CA, United States).
The resulting reads were trimmed for low-quality base calls and
Illumina adaptor sequence using cutadapt (Martin, 2011), and
then mapped to counts of known miRNAs using miR-MaGiC
(Russell et al., 2018) with reference to the miRbase (Kozomara
and Grifﬁths-Jones, 2014) v22.1 database. Samples passing
quality-control (≥1 × 105 mapped reads, having available
phenotypic information, and being within the 7–17 weeks
pseudoglandular period) and autosomal miRNAs passing preﬁltering criteria (non-zero counts in at least 25% of samples;
passes DESeq2 independent ﬁltering algorithm (Bourgon et al.,
2010); and not mapped to X or Y chromosome) were tested for
differences by sex. Using RUV-Seq (Risso et al., 2014), we also
obtained four RUVr factors representing unmeasured miRNA
expression heterogeneity for inclusion in regression models.

Study Reproducibility
Additional methodological details are available online
(Supplementary File S1: Detailed Methods). Code for the
statistical analyses and processed miRNA-sequencing data is
available at github. com/chooliu/miRNASexDimorphismFetalLung.
Raw and processed miRNA-sequencing data are pending deposition
approval at the NCBI GEO database.

RESULTS

Statistical Modeling of Sex Differences

Characteristics of the Human Fetal Lung
Tissue Samples

We evaluated if miRNA features differed by sex in two respects. First,
we identiﬁed autosomal miRNAs with varying average expression
levels between male and female samples regardless of sample
estimated post-conception age (i.e., effect present across the entire
pseudoglandular developmental stage). Using DESeq2 (Love et al.,
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miRNA-sequencing proﬁles were generated on human fetal lung
tissue samples ranging in gestational age from 54 to 117 days within
the pseudoglandular histological stage of human lung development.
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The ﬁnal set of 298 samples was comprised of 166 male (56%) and
132 (44%) female samples (Table 1). The same approximate
distribution of age ranges was observed in each sex (Figure 1; no
signiﬁcant difference in distribution based on Wilcoxon signed-rank
test, p = 0.41). Based on placental cotinine, our previously validated
biomarker of intrauterine smoke exposure, 139 (47%) of the samples
had been exposed to intrauterine smoke.

Lung miRNA Expression Proﬁles During the
Pseudgolandular Stage of Human Lung
Development
After pre-processing and quality control, our ﬁnal dataset
consisted of 809 miRNAs measured in 298 human lung
samples. Of the known sample physical characteristic
variables, gestational age appeared to explain the largest
variability in miRNA expression, with age explaining anywhere

FIGURE 1 | Human fetal lung tissue samples used for this analysis
demonstrates a similar distribution of estimated gestational ages observed in
each sex.

FIGURE 2 | (A) Top 10 miRNAs by p-value are depicted with their effect size expressed as log2 (fold change) with 95% conﬁdence intervals. Estimated fold changes
(miRNA counts in males compared to female samples) and q-values are also presented. (B,C) show example scatter plots of residualized miRNA levels (y-axis) plotted by
sex (x-axis). Residuals are displayed to illustrate sex-differences after adjusting for covariates including, age, age (Torday et al., 1981), smoke exposure, technical batch,
and the four RUV-inferred covariates to emphasize effects of sex.
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FIGURE 3 | Examples of sex-speciﬁc trajectories. Two miRNAs with statistically signiﬁcant age-by-sex interactions are plotted with residualized expression (y-axis)
across age (x-axis) during the pseudoglandular period differs by sex (indicated by color). Residuals are displayed to illustrate sex-by-age differences after adjusting for
smoke exposure, technical batch, and the four RUV-inferred covariates to emphasize patterns by age and sex.

from 0 to 52% of the variance in the expression of each miRNA.
In comparison, sex tended to explain only up to 8% of each
miRNA’s variance.

miRNA expression over the course of the pseudoglandular
period. Two examples of miRNAs with a signiﬁcant age-sex
interaction—hsa-let-7b-5p and hsa-miR-27b-3p—have their
expression levels by age plotted for illustration (Figure 3;
q-value < 0.05, full list of signiﬁcant results in Supplementary
Table S3). Sex-associated miRNAs identiﬁed in this manner also
were signiﬁcantly enriched in multiple pathways, including
epidermal growth factor (EGF) and muscarinic acetylcholine
receptor (mAChR) signaling (full results in Supplementary
Table S4).

Differential Expression of miRNAs by Sex
We detected 93 autosomal miRNAs with signiﬁcant
differential expression by sex after correcting for covariates.
A subset of differentially expressed miRNAs are shown in
Figure 2 (full list in Supplementary Table S1). The predicted
mRNA targets for each of these miRNAs are also provided in
Supplementary Table S1. Interestingly, these miRNAs
differentially expressed by sex include miRNAs predicted to
regulate gene expression targets with known roles in
pseudoglandular lung development: For example, hsa-miR27b-3p is predicted to regulate peroxisome proliferatoractivated receptor-γ (PPARγ) and hsa-miR-196a-5p is
predicted to regulate multiple Hox transcription factors
including homeobox B7 (HOXB7).
Pathway enrichment analyses also support the possibility
that sex-speciﬁc miRNAs may collectively regulate biological
pathways relevant to pseudoglandular lung development. Sexassociated miRNAs were signiﬁcantly enriched in numerous
pathways (gene set enrichment q-value < 0.05; full results in
Supplementary Table S2), including pathways with previously
identiﬁed roles in lung development, such as Wnt-signaling,
vascular endothelial growth factor (VEGF), ﬁbroblast growth
factor (FGF), and transforming growth factor beta (TGFβ)
signaling pathways. Sex-associated miRNAs were also
signiﬁcantly enriched with genes associated with androgen
and estrogen signaling.

DISCUSSION
While sex-speciﬁc differences that exist during in utero lung
development
are
well-recognized
by
histological
measurements, much remains to be understood about the
differences between males and females during early lung
development and their impact on subsequent disease risk.
Our study applies high-throughput, untargeted miRNAsequencing to rare human fetal lung tissue samples and
characterizes differences in miRNA expression by sex for
the ﬁrst time, highlighting novel regulatory features and
biological pathways that differ by sex in early prenatal lung
development. Sex-speciﬁc differences in these miRNAs may
potentially explain differences in lung maturation and in
subsequent respiratory disease susceptibility later in life that
differs between males and females.
We detected 93 miRNAs with signiﬁcantly different average
expression levels by sex during the pseudoglandular stage of
human lung development, as well as 129 miRNAs with
signiﬁcant age-by-sex interactions indicative of sex-speciﬁc
miRNA expression age-trajectories across the pseudoglandular
stage. The sex-speciﬁc miRNAs include some miRNAs previously
shown to impact lung development. For example, hsa-let-7b-5p
was both identiﬁed as signiﬁcantly differentially expressed
(higher levels in males on average throughout pseudoglandular

Sex-Speciﬁc miRNA Expression
Trajectories During Human Lung
Development
In addition, we detected 129 autosomal miRNAs with signiﬁcant
linear age-sex interactions; that is, a sex-speciﬁc age trajectory of
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period) and identiﬁed as a miRNA with a sex-speciﬁc trajectory
(expression increasing by age in males, but decreasing by age in
females). The let-7 family of miRNAs are well-known regulators
of human lung cell proliferation (Johnson et al., 2007), and in
mouse models appear to play crucial roles in regulating both the
timing and the cell differentiation processes associated with
airway branching, possibly mediated by let-7’s downstream
impacts on TGFβ signaling and epithelial-mesenchymal
interactions (Gulman et al., 2019).
We also identiﬁed other miRNAs with differences by sex that
have not been as richly characterized but are predicted to regulate
gene expression targets essential to lung development. For
example, hsa-miR-27b-3p was differentially expressed (higher
in males) and had a sex-speciﬁc age trajectory (decreasing by
age in males, increasing in females). A predicted regulatory target
of hsa-miR-27b-3p is the transcription factor PPARγ. PPARγ has
a multifaceted role in lung development, including the
modulation of inﬂammatory and cell differentiation processes
in the lung (Simon et al., 2006; Lecarpentier et al., 2019) and its
negative feedback with the Wnt/β-catenin and TGFβ signaling
pathways (Lecarpentier et al., 2019), two processes essential to
branching morphogenesis (De Langhe and Reynolds, 2008; Saito
et al., 2018). Disruption of PPARγ in mice models alters lung
volume and airway resistance (Simon et al., 2006). Consequently,
the differences in the levels and age-trajectories of let-7b-5p and
miR-27b-3p by sex observed here in human lung samples are one
plausible mechanism underlying differences in lung histology and
maturation rates between males and females during early human
lung development.
Given the importance of pseudoglandular stage in airway
development, it has long been hypothesized that insults to
lung development during this period contribute to the
developmental origins of chronic airway diseases (Stocks and
Sonnappa, 2013). Impaired gene expression during this period
likely alters susceptibility to chronic obstructive pulmonary
disease (COPD) (Warburton et al., 2006) and asthma (Melén
et al., 2011). These two diseases differ in etiology and
pathophysiology by sex. Because sex-differing pseudoglandular
miRNAs appear to regulate known airway development genes
and pathways, our ﬁndings support the potential for sex-differing
miRNA regulation very early in lung development to contribute
to later sex differences in airway disease. Our group has
previously shown that miRNA are biomarkers for abnormal
lung function in asthmatic children in a sex-speciﬁc way (Kho
et al., 2016b). In our current study, we note that our sex-differing
miRNA results overlapped with miRNA markers derived from
lung samples in COPD and asthma cases (Cañas et al., 2021), such
as hsa-miR-31-5p, hsa-miR-338-3p, and again the let-7 family
with the same direction of effect. Importantly, lung development
miRNAs that are differentially expressed by sex may be associated
with the pathogenesis of several different pulmonary diseases by
playing a key role in the inﬂammation that characterizes many
chronic lung diseases such as cystic ﬁbrosis, asthma, and
emphysema (Sessa and Hata, 2013).
Our ﬁndings also have links to other diseases with known sex
differences. For example, the higher levels of miR-27b-3p in
pseudoglandular male lung is notable because PPARγ agonists

Frontiers in Genetics | www.frontiersin.org

have been proposed for prevention and treatment of
bronchopulmonary dysplasia (BPD) (Simon et al., 2006), a
disease more common in males. We also detected sex-speciﬁc
pseudoglandular trajectories (increase by age at greater rates in
males) of miR-29a-3p and mir-150, two miRNAs with putative
BPD-associations but elusive causal impacts on BPD severity in
hypoxia-based experimental models (Nardiello and Morty, 2016).
Interestingly, the respective predicted gene targets for these genes
include collagen type 1 alpha 1 (COL1A1)/tropoelastin (ELN) and
homeobox A5 (HOXA5)/C-Myc are known to have structural
implications for early lung development (Schmidt et al., 2020).
To our knowledge, sex differences in miRNA expression in
early in human lung development have not been previously
proﬁled using high-throughput small RNA sequencing.
Previous miRNA-sequencing studies in mice have focused on
differential expression of miRNAs by sex during the later
canalicular and saccular stages (Mujahid et al., 2013).
Importantly, regulatory networks associated with murine
miRNAs that are differentially expressed by sex during lung
development have been shown to include androgen signaling
(Mujahid et al., 2013). Furthermore, mouse models also show that
miRNAs are modulated by androgens in developing lungs
(Bouhaddioui et al., 2016). Importantly, many of the impacts
of sex hormones established from mouse models in later lung
development may still apply to earlier lung development. These
observations include the ﬁnding that androgens alter fetal lung
ﬁbroblast maturation in murine lung via EGF and TGFβ
signaling events (Dammann et al., 2000). Additionally,
androgens appear to block endogenous glucocorticoids, which
are essential to normal lung development and are promoters of
surfactant production (Provost et al., 2013). More broadly,
androgens are thought to exert an inhibitory effect, while
estrogens exert a stimulatory effect on lung development
(Carey et al., 2007). Our results in early human lung
development mirror the animal data in the later stages of
gestation. Notably, pathway enrichment analysis of the
predicted gene expression targets of our sex-speciﬁc miRNAs
demonstrate enrichment in several sex-hormone related
pathways, including both estrogen metabolism and androgen
receptor signaling pathways.
We also demonstrate that the expression of several human
fetal lung miRNAs was modiﬁed by age, demonstrating changes
in gene expression across the pseudoglandular stage that varied
by sex. These results also suggest a link to sex-steroid regulation of
early lung development. The expression of hsa-let-7b increases
across the pseudoglandular stage in males, while its expression
does not change in females. Hsa-let-7b, a tumor-suppressor
miRNA, has been previously shown to be important in both
health and disease. In addition to its functions noted above, the
let-7 family has also been shown to be an essential regulator of
several endocrine systems. Transgenic mouse models have
demonstrated that in combination with Lin28, the let-7 family
of miRNAs are crucial to the timing of puberty and that
overexpression of this dyad may result in the delayed onset of
puberty (Zhu et al., 2010). While there are myriad mechanisms
that regulate the expression of this system including dietary
manipulation, it is well recognized that hormonal changes
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have been shown to have a signiﬁcant impact (Sangiao-Alvarellos
et al., 2015). Animal studies suggest that sex hormones may be
partly responsible for the sex-speciﬁc differences seen in lung
development. While these results suggest that sex-speciﬁc lung
development miRNAs may inﬂuence sex hormone metabolism
and signaling during the pseudoglandular stage of development,
additional conﬁrmatory studies are necessary to delineate the
impact of lung development miRNAs on sex hormone levels.
Although these results provide a comprehensive evaluation of
the sex-speciﬁc miRNA expression proﬁle of early human lung
development, there are several limitations to this study. Our
samples were obtained from a fetal tissue biorepository with
limited maternal and fetal information on each sample.
Therefore, we could not comment on confounders such as
maternal and fetal comorbidities. We attempted to address
potential unmeasured confounders (i.e., unknown intrauterine
exposures, maternal comorbidities, etc.) using the RUV method
to adjust for unexplained miRNA expression heterogeneity,
which includes possible unmeasured technical and biological
confounders. We also limited our current study to
investigation of the autosomal microRNAs. While there is a
high density of miRNA on the X chromosome, the functional
and statistical analyses of these loci remain complex and
incomplete (Di Palo et al., 2020). We were unable to do
validation of miRNA expression analyses due to the
limitations in the quantity of RNA available from these
extremely rare pseudoglandular samples. However, many of
the predicted gene expression targets have been previously
identiﬁed as demonstrated differential expression by sex in our
earlier work suggesting the biologic plausibility of our current
work (Kho et al., 2016a). In addition, our sex-speciﬁc miRNA
expression analysis of lung development was limited to fetal lung
tissue samples from the pseudoglandular stage of development.
Therefore, we are not able to determine the changes in the sexspeciﬁc miRNA proﬁles that occur during the later stages of
gestation, which may have implications for our understanding of
subsequent disease risk. Additionally, the fetal sample age was
estimated from days post-conception and not conﬁrmed by
histology, which could have introduced classiﬁcation bias
based on errors in estimation. Finally, although our results
suggest that sex-speciﬁc miRNAs are important in lung
development and may impact future disease risk, additional
functional validation in animal models would be necessary to
conﬁrm the impact of altering these miRNAs on subsequent
disease risk.
In conclusion, our study demonstrates sex-speciﬁc differences
in miRNA expression between the male and female developing
human lung and establishes their role in branching
morphogenesis and airway development during the
pseudoglandular time period. This study suggests that
miRNAs may regulate the sex differences seen in lung
development and that these differences in miRNA expression
may be potential mechanisms to explain sex-speciﬁc differences
in disease susceptibility to pulmonary disease later in life.
Furthermore, our ﬁndings provide evidence that sex-speciﬁc
miRNA expression proﬁles of lung development using human
fetal lung tissues can be used to elucidate novel biological
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mechanisms that regulate the sex differences of developmental
processes.

DATA AVAILABILITY STATEMENT
The datasets presented in this study can be found in online
repositories. The names of the repository/repositories and
accession number(s) can be found below: https://www.ncbi.
nlm.nih.gov/geo/, accession number: GSE200153.

ETHICS STATEMENT
The requirement for ethical review and approval was waived by
the University of Missouri-Kansas City Pediatric IRB, Partners
Human Research Committee IRB, and the Colorado Multiple
Institutional Review Board (COMIRB). Written informed
consent from the participants’ legal guardian/next of kin was
not required to participate in this study in accordance with the
national legislation and the institutional requirements.

AUTHOR CONTRIBUTIONS
NL wrote the ﬁrst draft of the manuscript, CL performed the
statistical analysis and contributed to manuscript writing. IY, LM,
DD, CV, KK, CW, AK, and SS contributed to conception and
design of the study. SY, MC, and VS helped with regulatory and
programmatic support. All authors contributed to manuscript
revision, read, and approved the submitted version.

FUNDING
This work was supported by NIH grants R01 HL125734 (PI: SS), R01
HL 097144 (PI: Weiss), P01HL132825 (PI: Weiss, DD), IGNITE First
in Women Precision Medicine Award from BWH R01 HG011393
(PI:DD).

ACKNOWLEDGMENTS
We would like to acknowledge Scott T. Weiss (Channing Division
of Network Medicine, Brigham and Women’s Hospital, Boston
MA), Robert P. Chase Channing Division of Network Medicine,
Brigham and Women’s Hospital, Boston MA), for his support of
this work. We would also like to thank J. Steven Leeder and Roger
Gaedigk (Children’s Mercy Hospital and Clinics, Kansas City,
MO) for their support of this work.

SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online at:
https://www.frontiersin.org/articles/10.3389/fgene.2022.762834/
full#supplementary-material

7

April 2022 | Volume 13 | Article 762834

Lin et al.

Sex-speciﬁc MicroRNAs in Lung Development

REFERENCES

Love, M. I., Huber, W., and Anders, S. (2014). Moderated Estimation of Fold
Change and Dispersion for RNA-Seq Data with DESeq2. Genome Biol. 15 (12),
1–21. doi:10.1186/s13059-014-0550-8
Lü, J., Qian, J., Chen, F., Tang, X., Li, C., and Cardoso, W. V. (2005). Differential
Expression of Components of the microRNA Machinery during Mouse
Organogenesis. Biochem. Biophysical Res. Commun. 334 (2), 319–323.
doi:10.1016/j.bbrc.2005.05.206
Martin, M. (2011). Cutadapt Removes Adapter Sequences from High-Throughput
Sequencing Reads. EMBnet j. 17 (1), 10. doi:10.14806/ej.17.1.200
Melén, E., Kho, A. T., Sharma, S., Gaedigk, R., Leeder, J. S., Mariani, T. J., et al.
(2011). Expression Analysis of Asthma Candidate Genes during Human and
Murine Lung Development. Respir. Res. 12 (1), 86. doi:10.1186/1465-992112-86
Mujahid, S., Logvinenko, T., Volpe, M. V., and Nielsen, H. C. (2013). MiRNA
Regulated Pathways in Late Stage Murine Lung Development. BMC Dev. Biol.
13 (1), 13. doi:10.1186/1471-213X-13-13
Naeye, R. L., Burt, L. S., Wright, D. L., Blanc, W. A., and Tatter, D. (1971). Neonatal
Mortality, the Male Disadvantage. Pediatrics 48 (6), 902–906. doi:10.1542/peds.
48.6.902
Naeye, R. L., Freeman, R. K., and Blanc, W. A. (1974). Nutrition, Sex, and Fetal
Lung Maturation. Pediatr. Res. 8 (3), 200–204. doi:10.1203/00006450197403000-00008
Nardiello, C., and Morty, R. E. (2016). MicroRNA in Late Lung Development and
Bronchopulmonary Dysplasia: the Need to Demonstrate Causality. Mol. Cell
Pediatr 3 (1), 19. doi:10.1186/s40348-016-0047-5
Pajak, M., and Simpson, T. I. (2021). miRNAtap: miRNAtap: microRNA Targets Aggregated Predictions. R Package Version 1.28.0.
Provost, P. R., Boucher, E., and Tremblay, Y. (2013). Glucocorticoid Metabolism in
the Developing Lung: Adrenal-like Synthesis Pathway. J. Steroid Biochem. Mol.
Biol. 138, 72–80. doi:10.1016/j.jsbmb.2013.03.004
Risso, D., Ngai, J., Speed, T. P., and Dudoit, S. (2014). Normalization of RNA-Seq
Data Using Factor Analysis of Control Genes or Samples. Nat. Biotechnol. 32
(9), 896–902. doi:10.1038/nbt.2931
Russell, P. H., Vestal, B., Shi, W., Rudra, P. D., Dowell, R., Radcliffe, R., et al. (2018).
MiR-MaGiC Improves Quantiﬁcation Accuracy for Small RNA-Seq. BMC Res.
Notes 11 (1), 1–8. doi:10.1186/s13104-018-3418-2
Saito, A., Horie, M., and Nagase, T. (2018). TGF-β Signaling in Lung Health and
Disease. Ijms 19 (8), 2460. doi:10.3390/ijms19082460
Sangiao-Alvarellos, S., Manfredi-Lozano, M., Ruiz-Pino, F., León, S., Morales, C.,
Cordido, F., et al. (2015). Testicular Expression of the Lin28/let-7 System:
Hormonal Regulation and Changes during Postnatal Maturation and after
Manipulations of Puberty. Sci. Rep. 5 (September), 1–13. doi:10.1038/srep15683
Schmidt, A. F., Kannan, P. S., Bridges, J., Presicce, P., Jackson, C. M., Miller, L. A.,
et al. (2020). Prenatal Inﬂammation Enhances Antenatal CorticosteroidInduced Fetal Lung Maturation. JCI insight 5 (24). doi:10.1172/jci.insight.
139452
Seaborn, T., Simard, M., Provost, P. R., Piedboeuf, B., and Tremblay, Y. (2010). Sex
Hormone Metabolism in Lung Development and Maturation. Trends
Endocrinol. Metab. 21 (12), 729–738. doi:10.1016/j.tem.2010.09.001
Sessa, R., and Hata, A. (2013). Role of microRNAs in Lung Development and
Pulmonary Diseases. Pulm. Circ. 3 (2), 315–328. doi:10.4103/2045-8932.
114758
Simon, D. M., Arikan, M. C., Srisuma, S., Bhattacharya, S., Tsai, L. W., Ingenito, E.
P., et al. (2006). Epithelial Cell PPARγ Contributes to normal Lung Maturation.
FASEB j. 20 (9), 1507–1509. doi:10.1096/fj.05-5410fje
Stocks, J., and Sonnappa, S. (2013). Early Life Inﬂuences on the Development of
Chronic Obstructive Pulmonary Disease. Ther. Adv. Respir. Dis. 7 (3), 161–173.
doi:10.1177/1753465813479428
Storey, J. D. (2002). A Direct Approach to False Discovery Rates. J. R. Stat. Soc. Ser.
B (Statistical Methodol. 64 (3), 479–498. doi:10.1111/1467-9868.00346
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette,
M. A., et al. (2005). Gene Set Enrichment Analysis: a Knowledge-Based
Approach for Interpreting Genome-wide Expression Proﬁles. Proc. Natl.
Acad. Sci. 102 (43), 15545–15550. doi:10.1073/pnas.0506580102
Torday, J. S., Nielsen, H. C., Fencl, Mde. M., and Avery, M. E. (1981). Sex
Differences in Fetal Lung Maturation. Am. Rev. Respir. Dis. 123 (2),
205–208. doi:10.1164/arrd.1981.123.2.205

Bhaskaran, M., Wang, Y., Zhang, H., Weng, T., Baviskar, P., Guo, Y., et al. (2009).
MicroRNA-127 Modulates Fetal Lung Development. Physiol. Genomics 37,
268–278. doi:10.1152/physiolgenomics.90268.2008.-MicroRNAs
Boucher, E., Provost, P. R., and Tremblay, Y. (2014). Ontogeny of Adrenal-like
Glucocorticoid Synthesis Pathway and of 20α-Hydroxysteroid
Dehydrogenase in the Mouse Lung. BMC Res. Notes 7 (1), 1–10. doi:10.
1186/1756-0500-7-119
Bouhaddioui, W., Provost, P. R., and Tremblay, Y. (2016). Expression Proﬁle of
Androgen-Modulated microRNAs in the Fetal Murine Lung. Biol. Sex. Differ. 7
(1), 1–13. doi:10.1186/s13293-016-0072-z
Bourgon, R., Gentleman, R., and Huber, W. (2010). Independent Filtering
Increases Detection Power for High-Throughput Experiments. Proc. Natl.
Acad. Sci. 107 (21), 9546–9551. doi:10.1073/pnas.0914005107
Cañas, J. A., Rodrigo-Muñoz, J. M., Sastre, B., Gil-Martinez, M., Redondo, N., and
del Pozo, V. (2021). MicroRNAs as Potential Regulators of Immune Response
Networks in Asthma and Chronic Obstructive Pulmonary Disease. Front.
Immunol. 11 (January), 1–19. doi:10.3389/ﬁmmu.2020.608666
Carey, M. A., Card, J. W., Voltz, J. W., Germolec, D. R., Korach, K. S., and Zeldin,
D. C. (2007). The Impact of Sex and Sex Hormones on Lung Physiology and
Disease: Lessons from Animal Studies. Am. J. Physiology-Lung Cell Mol. Physiol.
293 (2), L272–L278. doi:10.1152/ajplung.00174.2007
Dammann, C. E. L., Ramadurai, S. M., Mccants, D. D., Pham, L. D., and Nielsen, H.
C. (2000). Androgen Regulation of Signaling Pathways in Late Fetal Mouse
Lung Development1. Endocrinology 141 (8), 2923–2929. doi:10.1210/endo.141.
8.7615
De Langhe, S. P., and Reynolds, S. D. (2008). Wnt Signaling in Lung
Organogenesis. Organogenesis 4 (2), 100–108. doi:10.4161/org.4.2.5856
Di Palo, A., Siniscalchi, C., Salerno, M., Russo, A., Gravholt, C. H., and Potenza, N.
(2020). What microRNAs Could Tell Us about the Human X Chromosome.
Cell. Mol. Life Sci. 77 (20), 4069–4080. doi:10.1007/s00018-020-03526-7
Dweep, H., Sticht, C., Pandey, P., and Gretz, N. (2011). miRWalk - Database:
Prediction of Possible miRNA Binding Sites by "walking" the Genes of Three
Genomes. J. Biomed. Inform. 44 (5), 839–847. doi:10.1016/j.jbi.2011.05.002
Gulman, N. K., Armon, L., Shalit, T., and Urbach, A. (2019). Heterochronic
Regulation of Lung Development via the Lin28-Let-7 Pathway. FASEB j. 33
(11), 12008–12018. doi:10.1096/fj.201802702R
Harris, K. S., Zhang, Z., McManus, M. T., Harfe, B. D., and Sun, X. (2006).
Dicerfunction Is Essential for Lung Epithelium Morphogenesis. Pnas 103 (7),
2208–2213. doi:10.1073/pnas.0510839103
Johnson, C. D., Esquela-Kerscher, A., Stefani, G., Byrom, M., Kelnar, K.,
Ovcharenko, D., et al. (2007). The Let-7 microRNA Represses Cell
Proliferation Pathways in Human Cells. Cancer Res. 67 (16), 7713–7722.
doi:10.1158/0008-5472.CAN-07-1083
Kern, F., Fehlmann, T., Solomon, J., Schwed, L., Grammes, N., Backes, C., et al.
(2020). miEAA 2.0: Integrating Multi-Species microRNA Enrichment Analysis
and Workﬂow Management Systems. Nucleic Acids Res. 48 (W1),
W521–W528. doi:10.1093/nar/gkaa309
Kho, A. T., Chhabra, D., Sharma, S., Qiu, W., Carey, V. J., Gaedigk, R., et al. (2016).
Age, Sexual Dimorphism, and Disease Associations in the Developing Human
Fetal Lung Transcriptome. Am. J. Respir. Cell Mol Biol 54 (6), 814–821. doi:10.
1165/rcmb.2015-0326OC
Kho, A. T., Sharma, S., Davis, J. S., Spina, J., Howard, D., McEnroy, K., et al. (2016).
Circulating microRNAs: Association with Lung Function in Asthma. PLoS One
11 (6), e0157998–18. doi:10.1371/journal.pone.0157998
Kozomara, A., and Grifﬁths-Jones, S. (2014). MiRBase: Annotating High
Conﬁdence microRNAs Using Deep Sequencing Data. Nucl. Acids Res. 42
(D1), D68–D73. doi:10.1093/nar/gkt1181
Lecarpentier, Y., Gourrier, E., Gobert, V., and Vallée, A. (2019).
Bronchopulmonary Dysplasia: Crosstalk between PPARγ, WNT/β-Catenin
and TGF-β Pathways; the Potential Therapeutic Role of PPARγ Agonists.
Front. Pediatr. 7, 176. doi:10.3389/fped.2019.00176
Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005). Conserved Seed Pairing, Often
Flanked by Adenosines, Indicates that Thousands of Human Genes Are
microRNA Targets. Cell 120 (1), 15–20. doi:10.1016/j.cell.2004.12.035

Frontiers in Genetics | www.frontiersin.org

8

April 2022 | Volume 13 | Article 762834

Lin et al.

Sex-speciﬁc MicroRNAs in Lung Development

Publisher’s Note: All claims expressed in this article are solely those of the authors
and do not necessarily represent those of their afﬁliated organizations, or those of
the publisher, the editors and the reviewers. Any product that may be evaluated in
this article, or claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.

Vyhlidal, C. A., Riffel, A. K., Haley, K. J., Sharma, S., Dai, H., Tantisira, K. G., et al.
(2013). Cotinine in Human Placenta Predicts Induction of Gene Expression in Fetal
Tissues. Drug Metab. Dispos 41 (2), 305–311. doi:10.1124/dmd.112.049999
Warburton, D., Gauldie, J., Bellusci, S., and Shi, W. (2006). Lung Development and
Susceptibility to Chronic Obstructive Pulmonary Disease. Proc. Am. Thorac.
Soc. 3 (8), 668–672. doi:10.1513/pats.200605-122SF
Zhu, H., Shah, S., Shyh-Chang, N., Shinoda, G., Einhorn, W. S., Viswanathan, S. R., et al.
(2010). Lin28a Transgenic Mice Manifest Size and Puberty Phenotypes Identiﬁed in
Human Genetic Association Studies. Nat. Genet. 42 (7), 626–630. doi:10.1038/ng.593

Copyright © 2022 Lin, Liu, Yang, Maier, DeMeo, Wood, Ye, Cruse, Smith, Vyhlidal,
Kechris and Sharma. This is an open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) and
the copyright owner(s) are credited and that the original publication in this journal is
cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.

Conﬂict of Interest: The authors declare that the research was conducted in the
absence of any commercial or ﬁnancial relationships that could be construed as a
potential conﬂict of interest.

Frontiers in Genetics | www.frontiersin.org

9

April 2022 | Volume 13 | Article 762834

